• Magazine
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar
    • Editorial Deadlines
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • eBooks
    • eCourses
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Personal Growth
    • Podcast
  • Resource Centers
  • Products & Services
    • Buyer’s Guide
    • Products Directory
    • Submit a Product
    • Vendor Login
  • Datebook
    • Become an Events Poster
    • Post an Event
    • View Events
  • Jobs
    • Jobs
    • Post a Job
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us
    • Upload Advertising

Your Online Chiropractic Community

Chiropractic Economics Your Online Chiropractic Community
Subscribe
  • Home
  • Current Issue
  • News
  • Webinars
  • Chiropractic Research
  • Students
  • Coronavirus (COVID-19)

Theralase achieves success in destruction of listeria bacteria

Chiropractic Economics December 16, 2010

December 16, 2010 — Theralase Technologies Inc. (TSX-V: TLT) announces it has developed a new application for its Photo Dynamic Compounds (PDC’s); specifically, the destruction of Listeria Monocytogenes, a widely prevalent disease causing bacteria.

The patented Theralase PDCs have shown an ability to destroy bacteria in vitro when light activated, in new research performed at the renowned Princess Margaret Hospital, University Health Network (UHN). Future applications of the PDC technology in bacteria destruction may involve: food safety through food processing equipment sterilization, hospital treatment room sterilization, medical equipment sterilization, bacterial load elimination in wounds and other bacteria destruction applications.

Dr. Lothar Lilge, a scientist at the Ontario Cancer Institute located at Princess Margaret Hospital, University Health Network adds, “Our initial research has demonstrated that the PDC destruction of bacteria is possible. Under further research and development these PDCs represent an opportunity in the area of bacterial destruction for food safety and hospital sterilization.”

Roger Dumoulin-White, President and CEO of Theralase stated that, “We are encouraged that our Photo Dynamic Compounds are proving effective in many varied applications. Not only are these PDCs being shown to be effective in the destruction of a variety of cancer cells, in our on-going research at Princess Margaret Hospital, but now they are also being shown to be effective in the destruction of bacteria.

“Commercialization of these technologies becomes more and more apparent, as our research and development progresses, allowing us the opportunity of introducing these technologies to the world in a variety of diverse applications.

“Theralase in developing and commercializing this new application of our PDC technology plans to work with a variety of organizations, including: food processing organisations, academic institutions, hospitals, practitioners and medical equipment manufacturers interested in bacterial destruction applications.”

Source: Theralase, www.theralase.com

Related Posts

  • Theralase commences small animal pre-clinical trials for destruction of cancer cellsTheralase commences small animal pre-clinical trials for destruction of cancer cells
  • Theralase photo dynamic compounds help destroy cancerTheralase photo dynamic compounds help destroy cancer
  • Theralase expands board of directors with strong financing capabilitiesTheralase expands board of directors with strong financing capabilities
  • In vivo effects of low level laser therapy on inducible nitric oxide synthaseIn vivo effects of low level laser therapy on inducible nitric oxide synthase
  • Theralase’s cancer technology demonstrates vaccine-like propertiesTheralase’s cancer technology demonstrates vaccine-like properties
  • Theralase launches laser sales team dedicated to horse industryTheralase launches laser sales team dedicated to horse industry

Filed Under: Industry News, News

Current Issue

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

820 A1A N Highway W18,

Ponte Vedra Beach, FL 32082

Phone 904.285.6020

Fax 904.395.9118

CONTACT US »

Privacy Policy & Terms of Service

Copyright © 2021, All Rights Reserved

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just
fill out our form to request your FREE
subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Latest Chiropractic News

  • Shock Wave Technology provider debuts new name: Kinas Medical Technologies
  • Troy Healthcare debuts clinically-validated topical migraine and headache formula
  • Colorado allows chiropractors to give COVID-19 vaccine shots
x